HANNAH DYE: Open Payments
NPI 1831640911 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 20 payments from 8 companies in 2025. Trend: 2023 $527 · 2024 $351 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $101 |
| Exeltis, USA Inc. | 5 | $90 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $90 |
| Hologic Sales and Service, LLC | 2 | $43 |
| Biogen, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: Veozah, SLYND, NOVASURE, ZURZUVAE, ABRYSVO, MYOSURE TISSUE REMOVAL DEVICE, EVENITY, LILETTA.
Industry payments across MS — which companies pay providers there.
